78 episodes

Hear directly from the people whose work in genomics is shaping the way we think about science and our world. Listen as leading scientists discuss the impact of genomics with the Illumina Scientific Affairs team. Download or subscribe to our recurring podcasts.

Illumina Genomics Podcast Illumina, Inc.

    • Science

Hear directly from the people whose work in genomics is shaping the way we think about science and our world. Listen as leading scientists discuss the impact of genomics with the Illumina Scientific Affairs team. Download or subscribe to our recurring podcasts.

    Liquid biopsy NGS in cancer care

    Liquid biopsy NGS in cancer care

    Pashtoon Kasi, MD, MS, explains how liquid biopsy next-generation sequencing (NGS)-based testing can benefit cancer patients. Dr. Kasi presents four colorectal cancer patient cases for whom comprehensive genomic profiling (CGP) was done via liquid biopsy and results for clinically-relevant biomarkers were obtained in 7-8 days.

    • 5 min
    Genetic counselling in an era of prenatal screening, tools to support patient informed consent

    Genetic counselling in an era of prenatal screening, tools to support patient informed consent

    Listen to Genetic Counsellors Katie Ellis and Patricia Winters, Illumina discuss how more resource-efficient counselling methods are needed to support patient informed consent for genetic testing during pregnancy. They discuss the resources available for healthcare providers and expectant parents that allows them to make informed decisions.

    • 11 min
    Testing for NTRK Fusions

    Testing for NTRK Fusions

    Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next generation sequencing (NGS)-based testing for NTRK gene fusions. He presents the case of a patient who benefited from precision medicine based on the detection of a NTRK1 fusion by comprehensive genomic profiling.

    • 6 min
    Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

    Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

    Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and BRCA status in ovarian cancer patients. She presents the case of a patient who benefited from CGP testing for these biomarkers and shares the recent findings of the PAOLA-1 trial.

    • 5 min
    Pharmacogenomics: Barriers and Opportunities to Implementation

    Pharmacogenomics: Barriers and Opportunities to Implementation

    Dr. Ronald Leopold discusses implementation of pharmacogenomic screening in the healthcare industry. The conversation explores barriers to pharmacogenomic (PGx) program adoption, the future of precision medicine, and a paradigm shift away from reimbursement to value-based healthcare.

    • 26 min
    The Impact of Pharmacogenomics on Precision Medicine

    The Impact of Pharmacogenomics on Precision Medicine

    Why does a medication effectively “cure” one patient while having little to no effect, or worse, an adverse effect, on another? The answer may be found in our genome. Pharmacogenomics research aims to understand how genetic variations affect responses to medications, and can provide vital information for physicians as they choose a therapy regimen and prescribe dosage. Dr. Howard McLeod shares his thoughts on pharmacogenomics and the future of precision medicine.

    • 29 min

Top Podcasts In Science

ShoSalfa? | شسالفة؟
Imane
Hidden Brain
Hidden Brain, Shankar Vedantam
بودكاست علمي جدا
Kerning Cultures Network
StarTalk Radio
Neil deGrasse Tyson
The Genetics Podcast
Sano Genetics
بودكاست مشكاة
مشكاة

You Might Also Like